Jefferies Cuts Price Target on Marinus Pharma (MRNS) to $13 Following 4Q

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Jefferies Cuts Price Target on Marinus Pharma (MRNS) to $13 Following 4Q

Marinus Pharmaceuticals Provides Business Update and 2015 Financial Results

March 7, 2016 7:30 AM EST

RADNOR, Pa., March 07, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today provided a business update on its clinical development activities and reported its financial results for the year ended December 31, 2015.

Recent Clinical &... More